Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / MED BREAKTHGH
-
Number of holders
-
59
-
Total 13F shares, excl. options
-
1,463,462
-
Shares change
-
-3,849
-
Total reported value, excl. options
-
$66,604,390
-
Value change
-
-$332,962
-
Put/Call ratio
-
15.7%
-
Number of buys
-
20
-
Number of sells
-
-23
-
Price
-
$45.51
Significant Holders of ALPS ETF TR - MED BREAKTHGH (SBIO) as of Q3 2021
72 filings reported holding SBIO - ALPS ETF TR - MED BREAKTHGH as of Q3 2021.
ALPS ETF TR - MED BREAKTHGH (SBIO) has 59 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1,463,462 shares
.
Largest 10 shareholders include MORGAN STANLEY (238,482 shares), UBS Group AG (227,036 shares), BANK OF AMERICA CORP /DE/ (199,382 shares), WELLS FARGO & COMPANY/MN (196,596 shares), Cardan Capital Partners, LLC (89,900 shares), NTV Asset Management LLC (66,358 shares), ROYAL BANK OF CANADA (56,674 shares), LPL Financial LLC (48,373 shares), COMMONWEALTH EQUITY SERVICES, LLC (34,812 shares), and Beacon Pointe Advisors, LLC (32,450 shares).
This table shows the top 59 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.